kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,432
JPY
0
(0.00%)
Mar 13, 3:30 pm JST
15.25
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
9.0
PBR
0.60
Yield
3.70%
Margin Trading Ratio
22.59
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,432 JPY 15.27 USD
Previous Close Mar 12
2,432 JPY 15.29 USD
High Mar 13, 9:01 am
2,472 JPY 15.53 USD
Low Mar 13, 11:23 am
2,409 JPY 15.12 USD
Volume
53,400
Trading Value
0.13B JPY 0.81M USD
VWAP
2431.48 JPY 15.25 USD
Minimum Trading Value
243,200 JPY 1,525 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
123
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
90
1-Year High Sep 19, 2025
545
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 328,400 52,100 0.16
Feb 27, 2026 272,200 34,100 0.13
Feb 20, 2026 111,900 35,600 0.32
Feb 13, 2026 65,200 27,600 0.42
Feb 6, 2026 32,400 28,300 0.87
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.